13 June 2019
The State Duma adopted a bill to control the prices of vital and essential medicines in a final third reading, according to the information published on the website of the lower house of Russian parliament.
The draft law stipulates binding reregistration of producers’ maximum sale prices for vital and essential drugs if their price has reduced in a producing country and in the states where these medicines have been registered.
The bill also envisages that the producer’s registered maximum sale price for such drugs may be rerecorded increasingly not more frequently than once a year.
Amendments are proposed to the law on medicine circulation.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024